PATENT CLAIM ANALYSIS

Application Number: 15896420
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "336000"]

Abstract:
The invention herein generally relates to pharmaceutical formulations and methods of treating an overweight or obese subject, and overweight- or obesity-related conditions.

Claim (Index 22):
The method according to  claim 18 , wherein the weight loss agent is selected from the group consisting of: serotonin and noradrenergic re-uptake inhibitors; noradrenergic re-uptake inhibitors; selective serotonin re-uptake inhibitors; and intestinal lipase inhibitors.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12504722', '15093953', '14573495', '15484399', '13133060']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8620666010962211
- 35 USC 102 Novelty (BERT): 0.568990675783556
- Combined Prediction Score: 0.8327590085649547
- Mean Citation Score: 447.489908
- Max Citation Score: 585.4035
- Similarity Product: 312.9786351470948

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test